Phase 3 Readout~month

Phase 3 Topline: A Pivotal Phase 3 Study of FCX-007 (Genetically-Modified Autologous Human Dermal Fibroblasts) for Re

Indication
Recessive Dystrophic Epidermolysis Bullosa

Other upcoming events for CSTL

Phase 3 ReadoutPhase 3 Topline: Evaluation of Dabocemagene Autoficel (D-Fi; FCX-007; Genetically Modified Autologous Human Dermal Fi

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

Start FreeFull Calendar
    Phase 3 Topline: A Pivotal Phase 3 Study of FCX-007 (Genetically-Modified Autologous Human Dermal Fibroblasts) for Re — CSTL Phase 3 Readout | BioSniper